Bullous pemphigoid following the replacement of vildagliptin with anagliptin
- 7 July 2017
- journal article
- letter
- Published by Wiley in The Journal of Dermatology
- Vol. 44 (10) , e238-e239
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous PemphigoidJournal of Investigative Dermatology, 2016
- Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance DatabaseBritish Journal of Dermatology, 2016
- Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance databaseJournal of Clinical Pharmacy and Therapeutics, 2016
- Three Cases of Bullous Pemphigoid Associated with Dipeptidyl Peptidase-4 Inhibitors - One due to LinagliptinDermatology, 2016
- Drug‐induced pemphigoid: a review of the literatureJournal of the European Academy of Dermatology and Venereology, 2014